3.75 mg tirzepatide Tirz 75 (High-Mass) | Dual-Agonist Ligand Tirzepatide Shows Superior Weight Loss
Description
During the first 23 weeks, many patients experience appetite suppression and reduced food cravings before seeing the scale move significantly
Metabolic adaptation and reduced energy expenditure occur as the body responds to weight loss
[DOI] [PubMed] [Google Scholar] 20.Yamada Y, Seino Y
No similar reports have been published specifically for tirzepatide
doi: 10.1007/s00592-008-0080-5
The 48-week data shows 24.2 percent mean weight loss with retatrutide versus approximately 15 to 17 percent with semaglutide and 20 to 22 percent with tirzepatide
